Oral Sodium Fusidate (CEM-102) Versus Oral Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections

NCT02570490 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
716
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Arrevus Inc.